सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Union government caps trade margins at 30% to save ₹2,500 crore on cancer drugs

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·

Price capping and pharmaceutical regulation: a GS2 case study on reducing out-of-pocket healthcare costs.

Why in news

The Union government decided to cap trade margins at 30% for non-scheduled anti-cancer drugs to reduce out-of-pocket costs, which currently reach 75%.

Background

The National Pharmaceutical Pricing Authority found mark-ups on these drugs reaching up to 700%. An expert committee under the Directorate General of Health Services will finalize the list of drugs to be covered.

Facts for Prelims

  • BodyNational Pharmaceutical Pricing Authority: Body responsible for identifying mark-ups in drug pricing.
  • BodyDirectorate General of Health Services: Body overseeing the expert committee for drug list finalization.
  • FactTrade margin cap: 30% of the maximum retail price.
  • FactProjected annual savings: ₹2,500 crore.

Prelims practice question

Which body is responsible for identifying mark-ups in drug pricing as per the note?

  1. (a)Central Drugs Standard Control Organisation
  2. (b)Drug Controller General of India
  3. (c)National Health Authority
  4. (d)National Pharmaceutical Pricing Authority
Show answer

Answer: (d) National Pharmaceutical Pricing Authority — The National Pharmaceutical Pricing Authority is the body responsible for identifying mark-ups in drug pricing.

For Mains

Q. Discuss the measures required to reduce out-of-pocket expenditures in healthcare and the role of price capping in ensuring the accessibility of life-saving drugs.

Dimensions to cover in your answer

  • Market distortion: Balancing trade margin caps with the sustainability of the private pharmaceutical supply chain.
  • Regulatory oversight: Strengthening the National Pharmaceutical Pricing Authority's monitoring of non-scheduled drug mark-ups.

Keywords: Out-of-pocket expenditure · Price capping · Pharmaceutical regulation · Affordability · Public health policy

Read the full news →Source: The Hindu ↗

More Social Justice notes

All Social Justice current affairs →

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.